Similar articles

• The maturation of differentiation therapy.

  Cheson BD. Cheson BD. N Engl J Med. 1992 Aug 6;327(6):422-4. doi: 10.1056/NEJM199208063270612. N Engl J Med. 1992. PMID: 1625719 No abstract available.
• Prophylaxis of symptoms of hyperhistaminemia after the treatment of acute promyelocytic leukemia with all-trans retinoic acid.

  Shimamoto Y, Suga K, Yamaguchi M, Kuriyama K, Tomonaga M. Shimamoto Y, et al. Acta Haematol. 1994;92(2):109-12. doi: 10.1159/000204193. Acta Haematol. 1994. PMID: 7817703 Review.
• Scrotal ulceration induced by all-trans retinoic acid in a patient with acute promyelocytic leukemia.

  Mourad YA, Jabr F, Salem Z. Mourad YA, et al. Int J Dermatol. 2005 Jan;44(1):68-9. doi: 10.1111/j.1365-4632.2004.02008.x. Int J Dermatol. 2005. PMID: 15663666
• All-trans retinoic acid and short-time, high-dose cytarabine in two children with acute promyelocytic leukemia.

  Schmitt K, Zoubek A, Schwarz R, Tulzer G, Koller E, Krieger O, Lutz D, Gadner H. Schmitt K, et al. Med Pediatr Oncol. 1996 Apr;26(4):254-7. doi: 10.1002/(SICI)1096-911X(199604)26:4<254::AID-MPO6>3.0.CO;2-I. Med Pediatr Oncol. 1996. PMID: 8600337
• Acute promyelocytic leukemia: a paradigm for differentiation therapy.

  Grimwade D, Mistry AR, Solomon E, Guidez F. Grimwade D, et al. Cancer Treat Res. 2010;145:219-35. doi: 10.1007/978-0-387-69259-3_13. Cancer Treat Res. 2010. PMID: 20306254 Review.